Pettinga Financial Advisors’s X4 Pharmaceuticals XFOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$29K Hold
10,000
– – ﹤0.01% 158
2026
Q2
$46.7K Buy
+10,000
New +$41K 0.01% 155

Other funds holding XFOR

Pettinga Financial Advisors's XFOR Position: Q3 2026 in Review

Pettinga Financial Advisors held its X4 Pharmaceuticals (XFOR) position steady in Q3 2026 at 10,000 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #158.

Pettinga Financial Advisors first reported a position in XFOR in Q2 2026 and has held it in 2 quarters since. The position peaked at $46.7K in Q2 2026. 3 funds tracked by Wall St. Rank hold XFOR as of Q3 2026.

  • Pettinga Financial Advisors held 10,000 shares of X4 Pharmaceuticals worth $29K as of Q3 2026.
  • Pettinga Financial Advisors left its X4 Pharmaceuticals share count unchanged in Q3 2026.
  • X4 Pharmaceuticals made up ﹤0.01% of Pettinga Financial Advisors's portfolio in Q3 2026, its #158 holding.
  • Pettinga Financial Advisors first reported a position in X4 Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • Pettinga Financial Advisors's X4 Pharmaceuticals position peaked at $46.7K in Q2 2026.
  • 3 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2026.

Based on Pettinga Financial Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.